GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » 3-Year FCF Growth Rate

Genomma Lab InternacionalB de CV (MEX:LABB) 3-Year FCF Growth Rate : 10.10% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV 3-Year FCF Growth Rate?

Genomma Lab InternacionalB de CV's Free Cash Flow per Share for the three months ended in Mar. 2024 was MXN-0.17.

During the past 12 months, Genomma Lab InternacionalB de CV's average Free Cash Flow per Share Growth Rate was 37.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 10.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Genomma Lab InternacionalB de CV was 142.30% per year. The lowest was -59.50% per year. And the median was 12.40% per year.


Competitive Comparison of Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate falls into.



Genomma Lab InternacionalB de CV 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Genomma Lab InternacionalB de CV  (MEX:LABB) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Genomma Lab InternacionalB de CV 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines